Skip to main content

Table 2 Results summary

From: Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs

Assay

Cell line

Genetic modification / Treatment

Results compared to control

Proliferation

786-0 WT

PT2385

=

Clonogenic assay

786-0 WT

PT2385

=

RCC4 VHL

VHL overexpression

+

RCC4 WT

PT2385

=

Migration

786-0 WT

PT2385

=

786-0 WT

siHIF2α

=

RCC4 WT

PT2385

+

RCC4 VHL

VHL overexpression

+

Invasion

786-0 WT

PT2385

-

RCC4 VHL

VHL overexpression

=

RCC4 WT

PT2385

=

Sensitivity to statins

786-0 WT

siHIF2α

+

Sensitivity to terbinafine

786-0 WT

siHIF2α

-

  1. RCC4 VHL results are compared to RCC4 WT cells
  2. 786-0 siHIF2α results are compared to 786-0 siCON cells
  3. aPT2385 treatment results are compared to non-treated cells